Headquarters
251 LITTLE FALLS DR, WILMINGTON, DE 19808-1674, US
WILMINGTON, DE, US
IRAZU ONCOLOGY LLC
From the company
Irazu Oncology, LLC is a clinical-stage biotech founded in 2022 developing off-the-shelf cancer immunotherapies built on a proprietary bacterial outer membrane vesicle (OMV) platform. The platform creates customized, self-adjuvanted mono/multivalent therapeutic vaccines carrying tumor antigens and immune-activating signals. Its lead program, IRZ-03, is a first-in-class multimodal OMV immunotherapy targeting CEA, MUC1, and PD-L1 for checkpoint inhibitor-refractory solid tumors.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.